Research

Hormonal

Semaglutide treatment for type 2 diabetes does not directly cause retinal damage; observed early worsening of diabetic retinopathy is primarily driven by the magnitude and speed of HbA1c reduction rather than the drug itself.

If you have type 2 diabetes and are starting semaglutide, do not avoid it out of fear of blindness. The risk of retinopathy worsening is linked to how fast your blood sugar drops, not the drug itself. To stay safe, your doctor should check your eyes before starting, and may reduce your insulin or sulfonylurea dose to prevent a rapid glucose drop. Regular eye exams are essential.

GoodRefutesHIGH confidence
Semaglutide per se seems to cause no direct damage to the retina, and the reported adverse effects might even be ascribed to a bias in the trial design. ... the magnitude and speed of HbA1c reduction, a phenomenon also associated with insulin treatment and bariatric surgery.
Maja Cigrovski Berković et al. · World Journal of Diabetes · 2023

Why this rating

Based on multiple large CVOTs (SUSTAIN-6, LEADER, etc.) and meta-analyses, though the paper notes heterogeneity in DR adjudication methods.

Source

Semaglutide-eye-catching results

Maja Cigrovski Berković et al. · World Journal of Diabetes · 2023

DOI 10.4239/wjd.v14.i4.424

narrative_reviewCited 19×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →